It most likely won’t drop back to under $2 this close to the FDA announcement and has a better chance of having surprise good news to the upside. Look at the year chart and you can see that has a better chance to head back to $7 and if they get the FDA approval they now have a bigger market with means more $$. If they decide to go outside the US with TRULANCE or get bought out you are looking at $7-$10. The time to buy was from November to early January. Now you just wait and see. It is an investment not a daytrade
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.